Publications by authors named "Thomas Majda"

Claim this Profile
T
The Impact of Alteplase Coverage on Health Equity for the Treatment of Ischemic Stroke in the USA: A Distributional Cost-Effectiveness Analysis.
Thomas Majda, Elizabeth S Mearns, Stacey Kowal

Appl Health Econ Health Policy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling US health equity impacts of emicizumab for severe haemophilia A: aggregate distributional cost-effectiveness analysis.
Thomas Majda, Janet S Lee, Randall Curtis, Stacey L Kowal

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Generalized Risk-Adjusted Cost-Effectiveness Economic Model for Measuring the Value of Interventions That Delay Mobility Impairment Across Neurological Conditions.
Jason Shafrin, Jaehong Kim, Jacob Fajnor, Kyi-Sin Than, Elizabeth S Mearns, Thomas Majda

Value Health· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology.
Jason Shafrin, Kyi-Sin Than, Jacob Fajnor, Jaehong Kim, Elizabeth S Mearns, Thomas Majda

Forum Health Econ Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect Costs of Alzheimer's Disease: Unpaid Caregiver Burden and Patient Productivity Loss.
Julia Fox, Elizabeth S Mearns, Jing Li, Katherine L Rosettie, Thomas Majda

Value Health· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the Population Equity of Alzheimer Disease Treatments in the US.
Patricia G Synnott, Thomas Majda, Pei-Jung Lin, Daniel A Ollendorf, Yingying Zhu

JAMA Netw Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis